Previous Close | 1.1000 |
Open | 1.1500 |
Bid | 0.9000 x 1200 |
Ask | 1.1000 x 1300 |
Day's Range | 0.9203 - 1.1700 |
52 Week Range | 0.7000 - 8.4400 |
Volume | |
Avg. Volume | 307,930 |
Market Cap | 258.22M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.3470 |
Earnings Date | Mar 30, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.50 |
HENDERSON, Nev., March 31, 2023--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2022.
HENDERSON, Nev., March 31, 2023--P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the "Company"), today announced that it has entered into definitive agreements to sell securities in a private placement with a group of institutional investors. The lead institutional investors in the private placement are affiliates of Chicago Pacific Founders ("CPF") and Leavitt Partners. The transaction is expected to result in gross proceeds of
HENDERSON, Nev., March 30, 2023--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, announced that it will now release results for fourth-quarter 2022 and full-year ended December 31, 2022 on Friday, March 31, 2023 before the market open. In connection with this release, management will host a conference call and webcast on Friday, March 31, 2023 at 8:30 AM Eastern Time to provide a corporate and financial up